RecruitingNot ApplicableNCT07393958

Impact of Food Supplementation on Quality of Life in Patients With Endometriosis and Pelvic Pain.

Experimental Study of Quality of Life in Patients With Endometriosis and Pelvic Pain Treated With Doliral Dietary Supplementation Versus Placebo.

Sponsor

Arafarma Group, S.A.

Enrollment

60 participants

Start Date

Feb 26, 2026

Study Type

INTERVENTIONAL

Conditions

Endometriosis (Diagnosis)

Summary

This study examines whether the food supplement Doliral can improve quality of life and reduce pelvic pain in women with endometriosis, compared with placebo, over several weeks.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Food supplement (T1675) and Placebo for people with endometriosis (diagnosis). The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTFood supplement (T1675)

Doliral is the food supplement, which is the investigational product at this study.

OTHERPlacebo

Placebo is the control treatment.

Locations(1)

Hospital Clínic de Barcelona

Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07393958

Related Trials

Impact of Endotest on Patients' Quality of Life: a Cohort Study

NCT075608527 locations

Observational Study on the Use of Ultrasound to Recognize Superficial Endometriosis in a Specific Area of the Pelvis (the Uterosacral Ligaments)

NCT074278494 locations